NCT04961801 Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia Status WITHDRAWN Phase PHASE1/PHASE2
NCT04957901 The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study Status RECRUITING Phase N/A
NCT04940468 High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology Status COMPLETED Phase NA
NCT04931875 Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma Status UNKNOWN Phase N/A
NCT04910594 Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma Status UNKNOWN Phase PHASE3
NCT04904588 HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04898790 Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant Status RECRUITING Phase NA
NCT04873440 An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT04853277 Patient Reported Outcomes and Patient Education in Cellular Therapy Patients Status COMPLETED Phase NA
NCT04847050 A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy Status COMPLETED Phase PHASE2
NCT04837222 A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma Status COMPLETED Phase N/A
NCT04827810 A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer Status RECRUITING Phase PHASE1
NCT04818372 Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma Status UNKNOWN Phase PHASE1
NCT04797182 Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma Status UNKNOWN Phase PHASE2
NCT04764513 Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT Status UNKNOWN Phase PHASE1/PHASE2
NCT04746092 The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19 Status UNKNOWN Phase N/A